Metir plc Delivers 521% Revenue Surge and Expands Global Footprint in FY25 Financial Results

Robust Revenue Growth Fueled by Strategic Projects

For the fiscal year ending 31 December 2025, Metir plc achieved a remarkable 521% revenue growth, reaching A31.44 million compared to A30.23 million in 2024. This surge was primarily driven by increased sales of MicrotoxAE LX instruments and higher reagent volumes. Additionally, income from a major project in Qatar, involving the deployment of Continuous Toxicity Monitors (CTMs) for the state water authority Kahramaa, contributed significantly.

The Qatar project, executed in partnership with Avanceon Limited, underscores Metir's expertise in delivering large-scale environmental monitoring solutions. Providing continuous potable water monitoring across Doha, the initiative is expected to be fully operational in 2026. This project not only boosted revenue but also strengthened Metir's foothold in the Middle East market.

Improved Operational Efficiency and Cost Control

Metir's 2025 financial performance benefited from reduced operating expenses, which fell to A31.43 million from A31.59 million in 2024, reflecting disciplined cost management and enhanced operational efficiency. Consequently, the operating loss decreased to A30.87 million from A31.72 million the previous year.

The company reported a gross profit of A30.56 million, a significant turnaround from a gross loss of A30.13 million in 2024, demonstrating operational leverage from increased sales. Metir closed the year with cash and cash equivalents totaling A31.06 million, supported by successful fundraising rounds raising A30.85 million in June 2025 and A31.0 million in December 2025.

Technological Innovations and New Product Introductions

In 2025, Metir advanced its technology portfolio by launching the QuickChekAE Sulphate Reducing Bacteria (SRB) kits in June. This new product line has generated a fresh revenue stream and attracted strong interest from leading global energy firms.

The company also progressed its proprietary PFAS detection platform, completing successful field trials in Wales. Developed with Swansea University, this platform is moving towards commercialisation with a major US distribution partner. Moreover, Metir's collaboration with Aptamer Group plc on a real-time Pathogen Detector reached its first technical milestone, with Phase 2 underway.

Global Distributor Network Expansion

Following the reporting period, Metir expanded its international commercial reach by appointing authorised distributors in key regions including Saudi Arabia, Bahrain, Malaysia, Indonesia, Brunei, Senegal, the United Arab Emirates, and Egypt. This strategic expansion aims to increase market access across the Middle East, North Africa, Asia, and West Africa.

The broadened distributor network is expected to drive higher sales of MicrotoxAE LX and FX instruments alongside other technologies in Metir's portfolio, supporting the company’s strategy to accelerate international revenue growth through direct sales, regional partnerships, and major infrastructure projects.

Strategic Outlook and Growth Prospects

Entering 2026, Metir benefits from a stronger revenue foundation, diversified product offerings, and a robust balance sheet. Key priorities include scaling production of MicrotoxAE LX and FX instruments, expanding reagent and consumable sales, and converting SRB kit orders into recurring revenue.

The company is actively pursuing additional large-scale international CTM projects akin to the Qatar deployment. The PFAS detection platform and Pathogen Detector programme represent significant medium- to long-term value creation opportunities. The Board remains focused on prudent capital allocation and will provide ongoing shareholder updates.

Leadership and Governance Strengthening

During 2025, Metir enhanced its leadership team by appointing Dr Christopher Potts as Independent Non-Executive Director and Claire Smith as Chief Financial Officer (non-board). These appointments bolster governance and operational expertise, supporting the company’s growth strategy execution.

A dedicated business development function was also established to drive sales growth and expand the international distributor network. These strategic hires and organisational improvements position Metir to capitalise on emerging opportunities and sustain momentum.

Qatar CTM Project: A Milestone Success

The installation of 27 CTMs in Doha, Qatar, represents a landmark achievement for Metir. Delivered for Kahramaa, the state water authority, this project offers continuous potable water monitoring and reinforces Metir’s strategic presence in the Middle East. The company is positioned to secure a potential Phase 2 tender to extend CTM deployment across greater Doha.

Metir’s proprietary online live data MicrotoxAE technology was pivotal in this smart-city water quality monitoring project. Participation in a UK-backed trade mission to Saudi Arabia further highlights Metir’s commitment to expanding its regional footprint and pursuing additional water infrastructure opportunities.

Advances in PFAS Detection Technology

Metir’s proprietary PFAS detection platform addresses the escalating global concern over PFAS contamination. Successful field trials in Wales validated its world-class detection capabilities, and the first commercial deployment in the US with Nasdaq-listed Veralto marks a key milestone.

Collaboration with FIDCHEM to integrate AI and machine learning into the PFAS platform aims to enhance accessibility and simplify data interpretation. Metir’s acquisition of full ownership of the PFAS measurement methodology strengthens its competitive position in this growing market.